Primary Image

Generic Background Image

Clinical Trial

Training Hand Muscle Patterns For Stroke Survivors

IRB Protocol Number STU00078099


Kristen Triandafilou


The purpose of this study is two-fold:

  1. to investigate a new use of an allergy medicine, cyproheptadine (an anti-histaminic and anti-serotonergic agent), to reduce spasticity and muscle hyperexcitability and
  2. to evaluate the effectiveness of a new therapy using active practice of your arm and hand compared to passive stretching.

Based on chance, you will be assigned to one of the four groups

  1. drug and active training
  2. drug and passive stretching
  3. placebo and active training or
  4. placebo and passive stretching.

The investigators hypothesize that the group receiving the combined cyproheptadine and active movement therapy will have better outcomes than the groups receiving cyproheptadine or active movement therapy alone. 

Your involvement will last 13 weeks.  A 13-week study testing a new rehabilitation approach that combines a new occupational therapy with a new drug.  The training will focus on the hand and arm.  The drug dosage will be gradually increased over three weeks and then maintained during 6 weeks (18 sessions) of therapy. Evaluation sessions will occur throughout the study.

Who Can Participate

  • Experienced a single stroke at least 6 months ago
  • Continued impairment in your hand
  • Noticable  tightness in your hand (spasticity)
  • No Botox® injection in your arm within the past 6 months 
  • No history of seizure disorder


$20 per training session

$40 per evaluation session

Age Range

Age Range 21 - 80

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

Save now, read later.

More Studies Like This

view all

Latest Updates

view all